查尔斯河携手高端疫苗，共推新一代测序技术助力疫苗研发新篇章

美股速递

Aug 20

查尔斯河实验室（Charles River Laboratories）与高端疫苗生物制剂公司（Medigen Vaccine Biologics Corp）宣布达成战略合作，旨在借助新一代测序技术（Next Generation Sequencing）加速推进新型疫苗开发项目的进程。

这一合作将整合双方在生物医药领域的深厚积累与前沿技术优势，共同探索更高效、更精准的疫苗研发路径。通过新一代测序的应用，双方期望在疫苗研发的早期阶段便能实现更全面的病毒基因组分析，从而显著提升候选疫苗的筛选效率与安全性评估水平。

查尔斯河作为全球领先的合同研究组织，长期致力于为制药与生物技术企业提供全方位的研发支持服务。而高端疫苗则凭借其在疫苗领域的专注与创新能力，在亚太市场占据重要地位。此次强强联手，不仅有望缩短疫苗从实验室到临床的转化周期，更可能为应对未来突发公共卫生事件提供更具弹性的技术储备。

业内分析人士指出，新一代测序技术在疫苗研发中的应用正成为行业趋势，其高通量、高灵敏度的特性能够为抗原设计、病毒变异监测等关键环节提供海量数据支撑。双方此番合作，无疑将加速这一技术从科研走向产业化落地的步伐。

展望未来，查尔斯河与高端疫苗的协同创新，或将为全球疫苗开发树立新的技术标杆，惠及更广泛的人群健康需求。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1182169661"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182169661\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182169661?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-08-20 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182169661","market":"us","top_or_hot":-1,"title":"查尔斯河携手高端疫苗，共推新一代测序技术助力疫苗研发新篇章","media":"美股速递","content":"<p>查尔斯河实验室（Charles River Laboratories）与高端疫苗生物制剂公司（Medigen Vaccine Biologics Corp）宣布达成战略合作，旨在借助新一代测序技术（Next Generation Sequencing）加速推进新型疫苗开发项目的进程。</p>\n<p>这一合作将整合双方在生物医药领域的深厚积累与前沿技术优势，共同探索更高效、更精准的疫苗研发路径。通过新一代测序的应用，双方期望在疫苗研发的早期阶段便能实现更全面的病毒基因组分析，从而显著提升候选疫苗的筛选效率与安全性评估水平。</p>\n<p>查尔斯河作为全球领先的合同研究组织，长期致力于为制药与生物技术企业提供全方位的研发支持服务。而高端疫苗则凭借其在疫苗领域的专注与创新能力，在亚太市场占据重要地位。此次强强联手，不仅有望缩短疫苗从实验室到临床的转化周期，更可能为应对未来突发公共卫生事件提供更具弹性的技术储备。</p>\n<p>业内分析人士指出，新一代测序技术在疫苗研发中的应用正成为行业趋势，其高通量、高灵敏度的特性能够为抗原设计、病毒变异监测等关键环节提供海量数据支撑。双方此番合作，无疑将加速这一技术从科研走向产业化落地的步伐。</p>\n<p>展望未来，查尔斯河与高端疫苗的协同创新，或将为全球疫苗开发树立新的技术标杆，惠及更广泛的人群健康需求。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>查尔斯河携手高端疫苗，共推新一代测序技术助力疫苗研发新篇章</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n查尔斯河携手高端疫苗，共推新一代测序技术助力疫苗研发新篇章\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-08-20 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>查尔斯河实验室（Charles River Laboratories）与高端疫苗生物制剂公司（Medigen Vaccine Biologics Corp）宣布达成战略合作，旨在借助新一代测序技术（Next Generation Sequencing）加速推进新型疫苗开发项目的进程。</p>\n<p>这一合作将整合双方在生物医药领域的深厚积累与前沿技术优势，共同探索更高效、更精准的疫苗研发路径。通过新一代测序的应用，双方期望在疫苗研发的早期阶段便能实现更全面的病毒基因组分析，从而显著提升候选疫苗的筛选效率与安全性评估水平。</p>\n<p>查尔斯河作为全球领先的合同研究组织，长期致力于为制药与生物技术企业提供全方位的研发支持服务。而高端疫苗则凭借其在疫苗领域的专注与创新能力，在亚太市场占据重要地位。此次强强联手，不仅有望缩短疫苗从实验室到临床的转化周期，更可能为应对未来突发公共卫生事件提供更具弹性的技术储备。</p>\n<p>业内分析人士指出，新一代测序技术在疫苗研发中的应用正成为行业趋势，其高通量、高灵敏度的特性能够为抗原设计、病毒变异监测等关键环节提供海量数据支撑。双方此番合作，无疑将加速这一技术从科研走向产业化落地的步伐。</p>\n<p>展望未来，查尔斯河与高端疫苗的协同创新，或将为全球疫苗开发树立新的技术标杆，惠及更广泛的人群健康需求。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0128526141.USD","symbol_name":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","start_time":0,"source_url":"","article_id":"1182169661","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182169661","pubTimestamp":1787227282,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"查尔斯河实验室与高端疫苗生物制剂公司宣布达成战略合作，旨在借助新一代测序技术加速推进新型疫苗开发项目的进程。查尔斯河作为全球领先的合同研究组织，长期致力于为制药与生物技术企业提供全方位的研发支持服务。展望未来，查尔斯河与高端疫苗的协同创新，或将为全球疫苗开发树立新的技术标杆，惠及更广泛的人群健康需求。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK4588":"碎股","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","BK4121":"生命科学工具和服务","CRL":"查尔斯河","BK4530":"医药外包概念"},"translate_title":"Charles River joins hands with high-end vaccines to promote a new generation of sequencing technology to help a new chapter in vaccine research and development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1},"content_text":"查尔斯河实验室（Charles River Laboratories）与高端疫苗生物制剂公司（Medigen Vaccine Biologics Corp）宣布达成战略合作，旨在借助新一代测序技术（Next Generation Sequencing）加速推进新型疫苗开发项目的进程。\n这一合作将整合双方在生物医药领域的深厚积累与前沿技术优势，共同探索更高效、更精准的疫苗研发路径。通过新一代测序的应用，双方期望在疫苗研发的早期阶段便能实现更全面的病毒基因组分析，从而显著提升候选疫苗的筛选效率与安全性评估水平。\n查尔斯河作为全球领先的合同研究组织，长期致力于为制药与生物技术企业提供全方位的研发支持服务。而高端疫苗则凭借其在疫苗领域的专注与创新能力，在亚太市场占据重要地位。此次强强联手，不仅有望缩短疫苗从实验室到临床的转化周期，更可能为应对未来突发公共卫生事件提供更具弹性的技术储备。\n业内分析人士指出，新一代测序技术在疫苗研发中的应用正成为行业趋势，其高通量、高灵敏度的特性能够为抗原设计、病毒变异监测等关键环节提供海量数据支撑。双方此番合作，无疑将加速这一技术从科研走向产业化落地的步伐。\n展望未来，查尔斯河与高端疫苗的协同创新，或将为全球疫苗开发树立新的技术标杆，惠及更广泛的人群健康需求。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}